1. Introduction {#sec1-ijms-19-02556}
===============

Fat tail is a stress resistance trait in sheep. Some sheep breeds hoard considerable fat in their tails in the forage-rich season, which protects against starvation during lack of forage and cold conditions \[[@B1-ijms-19-02556]\]. Altay sheep are a typical fat-tailed breed, with tail fat representing about a quarter of their carcass weight \[[@B2-ijms-19-02556]\]. These animals are famous for their high meat production and strong adaptability to extreme environments \[[@B3-ijms-19-02556]\]. Fat tail is the result of long-term evolution and natural selection of breeds in a rugged living environment. During warm periods with lush grass growth, adipose tissue is deposited in the rump of Altay sheep. Rump fat undergoes massive decomposition to provide energy for metabolism and resistance to cold weather in periods lacking grass growth, and the tail becomes flat and thin. However, this type of high fat storage ability is associated with a number of problems, in that the economic value of the carcass is reduced (the amount of forage to deposit 1 kg of fat is sufficient to produce 2 kg of meat), and the market share is reduced because of the growing demand for a healthy diet. In Xinjiang, fat-tailed sheep constitute the main breed. The reason for fat deposition in the tail is unclear, and the specific genetic, physiological, and biochemical molecular mechanisms underlying Altay sheep tail fat deposition and mobilization remain to be elucidated.

Fat tissue is not only an important component of the carcass but also participates in many physiological and biochemical responses in the animal body, providing energy for life activities. Adipose tissue is predominantly formed by adipocytes originating from mesenchymal stem cells (MSC). These cells progressively differentiate and eventually form mature adipocytes \[[@B4-ijms-19-02556]\]. The energy storage ability of the adipose tissue (the largest energy storage organ of the body) is related to triglycerides (TG). Adipose tissue can be divided into white adipose tissue (WAT) and brown adipose tissue (BAT). WAT plays an important role in energy balance, storing energy in the form of TG when the body has abundant nutrition. During periods of energy deficiency, WAT is released as free fatty acid (FFA) \[[@B5-ijms-19-02556],[@B6-ijms-19-02556]\]. A small amount of BAT in the body can lead to oxidative decomposition of fat tissue and heat release. Two characteristics of fat deposition have been reported, specifically, the increase in adipocyte number and the enlargement of adipocyte volume. During the embryonic period, adipose tissue development is evident and mainly based on the increase in adipocyte number. After the animal is born, the adipocyte number changes to a limited extent, and fat deposition and synthesis are mainly dependent on the enlargement of adipocyte volumes \[[@B7-ijms-19-02556]\]. Numerous transcription factors, enzyme-encoding genes, and signaling pathways are involved in fat synthesis and decomposition, such as lipoprotein lipase (LPL) \[[@B8-ijms-19-02556]\], CCAAT/enhancer-binding protein (C/EBP) \[[@B9-ijms-19-02556]\], peroxisome proliferator activated receptor (PPAR) \[[@B10-ijms-19-02556]\], fatty acid synthase (FAS) \[[@B11-ijms-19-02556]\], hormone-sensitive lipase (HSL) \[[@B12-ijms-19-02556]\], and adipose triglyceride lipase (ATGL) \[[@B13-ijms-19-02556]\]. In addition, adipocytes secrete a number of cytokines and hormones related to fat metabolism, including adiponectin (APN, ADIPOQ) \[[@B14-ijms-19-02556]\], resistin (RETN) \[[@B15-ijms-19-02556]\], leptin (LEP) \[[@B16-ijms-19-02556]\], visfatin \[[@B17-ijms-19-02556]\], and tumor necrosis factor-α (TNF-α) \[[@B18-ijms-19-02556]\], along with key molecules of signaling pathways, such as peroxisome proliferator-activated receptor (PPAR), AMP-activated protein kinase (AMPK), and mitogen-activated protein kinase (MAPK). However, limited research has been conducted to date on the proteins associated with fat deposition and on mobilization-related genes and signaling pathways.

Isobaric tags for relative or absolute quantitation (iTRAQ) is a high-throughput proteomic technology that allows quantitative comparisons of protein abundance. Until now, limited studies have applied iTRAQ technology to assess proteins in Altay sheep \[[@B19-ijms-19-02556]\]. In the current investigation, we recorded the rump widths and determined serum lipid markers using nine Altay sheep from three age groups (three months old, yearling, and adult) and compared the tail tissue adipocyte sizes of nine Altay sheep from three age groups (young lamb, six months old, and adult), three Wool sheep (adult), and six Altay sheep from "free-feeding" (FF) and "persistent starvation" (PS) groups. In particular, the FF and PS groups could simulate the extreme states of rump fat deposition and mobilization of Altay sheep. Next, we determined the key differentially expressed proteins in the FF and PS groups using iTRAQ technology and the expression patterns of fat synthesis and decomposition genes in the two extreme states. Changes in the expression patterns of the proteins involved in these pathways provide a basis for clarifying the molecular mechanisms underlying rump fat deposition and mobilization in Altay sheep, which may be effectively utilized as a model for human metabolism, nutritional physiology, and diabetes research.

2. Results {#sec2-ijms-19-02556}
==========

2.1. Persistent Starvation Experiment {#sec2dot1-ijms-19-02556}
-------------------------------------

To simulate the extreme states of rump fat deposition and mobilization, three Altay adult ewes were provided with limited feed during the winter months in Xinjiang, China. During the gradual reduction in feeding, Altay sheep showed a strong appetite, a good mental status, and slightly reduced weights. In the subsequent four weeks, free drinking water was provided, but no feed. The fold temperatures were maintained between −28 °C and −15 °C. The sheep became anxious but showed no evidence of a pathological state. The foraging desire was extremely strong. After feed deprivation, the average weight was reduced by 11 kg. The rump became loose and soft, with a significant reduction in fat volume.

2.2. Changes in Rump Width and Serum Lipid Markers {#sec2dot2-ijms-19-02556}
--------------------------------------------------

The average rump widths (cm) of Altay sheep in each age group (three months old, yearling, and adult) were monitored. During the course of the year, the rump width changed significantly from 10.1 cm to 20.9 cm, 20.8 cm to 23.6 cm, and 25.2 cm to 27.7 cm, in the three-month-old lamb, yearling, and adult groups, respectively. Under cold winter conditions, the rump width values appeared to show a slight downward trend ([Figure 1](#ijms-19-02556-f001){ref-type="fig"}A). The data suggest that under free-feeding conditions, the rump fat contents in Altay sheep respond to the corresponding environmental conditions, especially in adult sheep. Notably, no decrease in rump width was obvious for the three-month-old group.

Serum samples were collected from three-month-old, yearlings, and adult Altay sheep for the evaluation of lipid markers. Our results disclosed no seasonal variability in the serum levels of APN ([Figure 1](#ijms-19-02556-f001){ref-type="fig"}B) and LEP ([Figure 1](#ijms-19-02556-f001){ref-type="fig"}C) in Altay sheep. The APN content in adult sheep reached a peak of 5.8 ng/mL in February 2013, and that in yearling and three-month-old sheep peaked in January 2013 at 5.5 ng/mL and 2.9 ng/mL, respectively. The levels in yearling and adult sheep were significantly higher than those in three-month-old sheep. TG ([Figure 1](#ijms-19-02556-f001){ref-type="fig"}D) and total cholesterol (TCH) ([Figure 1](#ijms-19-02556-f001){ref-type="fig"}E) levels in sheep in all groups were not significantly different. However, the FFA levels showed an obvious peak during the long winter period in Xinjiang, China. For example, the FFA concentration in adult sheep increased from 23 μg/mL in January to 37 μg/mL in March and subsequently decreased to 22 μg/mL in May. This phenomenon was more evident in adult sheep than in three-month-old and yearling animals ([Figure 1](#ijms-19-02556-f001){ref-type="fig"}F).

2.3. Cell Volumes of Sheep Adipocytes {#sec2dot3-ijms-19-02556}
-------------------------------------

The adipose tissue from all groups were collected via operative procedures, and the relative frozen sections were examined. The examination of the size of the adipocytes from the tail fat of Altay sheep in each age group (young lamb, six months old, and adult) revealed an increase in adipocyte volume with age ([Figure 2](#ijms-19-02556-f002){ref-type="fig"}A). Within the same unit area, the number of adipocytes in young lamb, six-month-old sheep, and adult sheep groups was determined as 56, 33, and 26, respectively, with the cell volumes of six-month-old and adult sheep being significantly larger than those of young lambs. We then compared the adipocyte size of Altay sheep with that of Wool sheep. The results showed that the adipocytes of Altay sheep tail fat displayed a nearly circular cell morphology with relatively uniform sizes, in contrast to those of the control group (Wool sheep) that showed a non-uniform, irregular morphology. Within the same unit area, the number of adipocytes in Altay and Wool sheep was estimated as 14 and 18, respectively. The cell-filling degree was markedly higher in Altay than in Wool sheep ([Figure 2](#ijms-19-02556-f002){ref-type="fig"}B). Meanwhile, six selected healthy Altay sheep of similar weights were subdivided into FF and PS groups. The adipose tissue from both groups was collected via operative procedures, and the related frozen sections were examined. Within the same unit area, the number of adipocytes in the FF and PS groups was estimated as 14 and 20, respectively. Moreover, the cells of sheep from the PS group were flat and spindle-shaped, with a lower filling degree than those from the FF group ([Figure 2](#ijms-19-02556-f002){ref-type="fig"}C), suggesting a significant decomposition of intracellular lipids. On the basis of these data, we propose that the persistent starvation model developed in this study achieved the expected effect and effectively simulated the deposition and mobilization of tail fat in Altay sheep in the natural environment.

2.4. iTRAQ Analysis of Proteins Participating in Altay Sheep Rump Fat Metabolism under Persistent Starvation {#sec2dot4-ijms-19-02556}
------------------------------------------------------------------------------------------------------------

To profile global protein expression changes in the rump in response to tail fat mobilization, we subjected Altay sheep to persistent starvation ([Figure S1A](#app1-ijms-19-02556){ref-type="app"}). The proteomes of Altay sheep rump adipose tissues from the FF and PS groups were compared using three independent samples as biological replicates. After digestion of the extracted proteins with trypsin, purified Tandem Mass Tag-labeled peptides from the FF and PS replicates were pooled. All samples were analyzed via LC--MS/MS, and the raw spectra were processed using MaxQuant ([Figure S1B](#app1-ijms-19-02556){ref-type="app"}). Consequently, we identified 7401 unique peptides and about 1610 proteins in rump adipose tissues labeled with each channel with high confidence, which were subsequently classified into 14 functional categories according to gene ontology ([Figure 3](#ijms-19-02556-f003){ref-type="fig"}). Among the proteins detected, 112 were differentially expressed ([Table 1](#ijms-19-02556-t001){ref-type="table"}). Compared with the FF group, 54 proteins were downregulated and 58 were upregulated in the PS group. For instance, the expression of ADIPOQ and complement factor D (CFD) was higher in the PS than in the FF group, while Cell death-inducing DFFA-like effector C (CIDEC) expression in the PS group was downregulated to a greater extent than in the FF group. A number of genes closely related to lipid metabolism were further screened ([Table 2](#ijms-19-02556-t002){ref-type="table"}). Additionally, we performed BLAST analysis of target protein sequences using the KEGG genes database of goat protein sequences, followed by grouping of the 112 identified protein sequences into 99 KEGG pathways for pathway analysis and screening of individual pathways related to fat deposition and mobilization ([Table 3](#ijms-19-02556-t003){ref-type="table"}).

2.5. qPCR Analysis of Differentially Expressed Candidate Genes {#sec2dot5-ijms-19-02556}
--------------------------------------------------------------

To explore the expression patterns of fat synthesis and decomposition-related candidate genes, we exposed sheep to persistent starvation and free-feeding conditions to simulate the two extreme states promoting tail fat mobilization and deposition. qPCR was applied to analyze the expression of fat synthesis- and decomposition-related candidate genes in Altay tail fat before (FF group) and after (PS group) the starvation test, with glyceraldehyde 3-phosphate dehydrogenase (*GAPDH*) as the reference gene. The relative expression levels of fat metabolism genes were calculated using the 2^−ΔΔ*C*T^ method. The levels of *ADIPOQ* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}A), *RETN* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}B), *LPL* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}C), *Apo-AI* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}D), *HSP72* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}E), *LEP* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}F), and *CFD* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}G) in the PS group were significantly higher than those in the FF group (*p* ≤ 0.01), while *CIDEC* ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}H) expression was markedly lower in the PS group (*p* ≤ 0.01). Simultaneously, we examined the expression patterns of non-lipid metabolism-related genes. The expression of p120 GTPase activating protein (*p120GAP*) ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}I) in the PS group was significantly higher than that in the FF group (*p* ≤ 0.01), while filamin A (*FLNA*) ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}J) and integrin alpha 6 (*ITGA6*) ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}K) levels were significantly higher in the FF group (*p* ≤ 0.01), and protein phosphatase 2A (*PP2A*) ([Figure 4](#ijms-19-02556-f004){ref-type="fig"}L) level was relatively higher in the FF group (0.01 ≤ *p* ≤ 0.05) than in the PS group. The qPCR results disclosed consistent mRNA and protein expression patterns of these genes, supporting the accuracy of our iTRAQ-derived proteomics data. Our findings indicate that both transcriptional and proteomic groups are involved in the adipose biology processes of tail fat deposition and mobilization in the two extreme states.

3. Discussion {#sec3-ijms-19-02556}
=============

3.1. Altay Sheep Present an Ideal Model for Studying Animal Fat Metabolism {#sec3dot1-ijms-19-02556}
--------------------------------------------------------------------------

Altay sheep have evolved into a fat-rump breed with superior environmental adaptability, naturally selected by lengthy environmental stress and human factors. Owing to their characteristic rump fat deposition and mobilization in response to seasonal changes, Altay sheep present an ideal model to investigate the molecular mechanisms underlying subcutaneous fat deposition and mobilization processes in the tails of animals. In this study, we recorded rump widths (cm) of Altay sheep from three age groups (three months old, yearling, adult). Rump width decrease was not obvious in three-month-old sheep, which may be attributable to their strong growth tendency. We additionally monitored blood lipid markers for one year in three-month-old, yearling, and adult Altay sheep. The TG, TCH, and FFA levels in Altay sheep from all three stages were relatively constant, with no significant differences among the groups (*p* ≥ 0.05). Our results indicate that the blood lipid markers fluctuate within the normal range during continuous fat deposition in healthy sheep. The sectioning and hematoxylin-eosin (HE) staining results showed that, with increasing age, rump adipocyte volume and width are correspondingly increased. Cell size was positively correlated with the fat deposition ability, in keeping with the earlier finding that adipocyte volume increases with age in animals \[[@B20-ijms-19-02556]\]. In addition, the volume of tail adipocytes of Altay sheep was significantly larger than that of low-fat wool sheep at the same growth stages. These data clearly show that Altay sheep have a stronger ability to deposit tail fat than wool sheep.

To further clarify the specific mechanisms underlying fat mobilization, Altay sheep were subjected to persistent starvation involving a progressive simulation of fat mobilization through food restriction. In the PS group, the degree of filling of the tail adipocytes was significantly lower than that in the FF group, consistent with the findings of Gondret et al. \[[@B21-ijms-19-02556]\]. These results support the theory that in Altay sheep, rump decomposition is accelerated, and storage fat consumed to produce heat and energy that promote resistance to cold weather and facilitate the maintenance of body temperature and physiological activities under conditions of persistent starvation.

3.2. Roles of Specific Hormones in Lipid Metabolism {#sec3dot2-ijms-19-02556}
---------------------------------------------------

We identified 7401 unique peptides and about 1610 proteins in the FF and PS groups using iTRAQ protein sequencing. Overall, 112 differentially expressed proteins were identified in the two groups. Among these, the known fat-specific hormones LEP and ADIPOQ displayed increased secretion in the persistent starvation state (*p* ≤ 0.01). These two proteins are able to suppress the appetite of Altay sheep by inhibiting the secretion of hypothalamus neuropeptide Y and reducing energy intake and to increase the expression of lipolytic enzymes via the AMPK pathway to promote fat mobilization \[[@B22-ijms-19-02556],[@B23-ijms-19-02556]\]. LEP is reported to stimulate the central glucosensory neurons, increase sympathetic nerve activity, and promote the release of peripheral noradrenaline to enhance the secretion of lipolysis hormones and accelerate lipid droplet decomposition. In addition, ADIPOQ activates the p38-MAPK and PPARα signal pathways to increase energy metabolism \[[@B24-ijms-19-02556]\]. The combined action of these two hormones may ultimately accelerate the decomposition of rump fat and promote the oxidation of fatty acids to supply energy.

3.3. Synergistic Actions of Key Lipid Metabolism-Related Hormones and Signaling Pathways {#sec3dot3-ijms-19-02556}
----------------------------------------------------------------------------------------

Under conditions of persistent starvation, the activation of specific signaling pathways closely related to lipid metabolism constitutes another main mechanism for promoting rump decomposition to supply energy in Altay sheep. *Apo-AI* and *LPL* mRNA and protein levels in the PS group were significantly higher than in the FF group (*p* ≤ 0.01). These two differentially expressed proteins participate in the PPAR pathway and have been identified as downstream target genes of PPARα and PPARβ, respectively. *LPL* is reported to promote the exchange between lipoproteins and lipids through the regulation of triglyceride hydrolysis and assist in lipoprotein intake and the acceleration of fatty acid oxidation rate \[[@B25-ijms-19-02556],[@B26-ijms-19-02556]\]. Apo-AI is the main component of plasma high-density lipoproteins that accelerate the cholesterol transfer rate and the decomposition rate of lipids \[[@B27-ijms-19-02556]\]. The two proteins promote fatty acid β-oxidation. The differentially expressed LEP and ADIPOQ proteins in our experiments were simultaneously enriched in the AMPK signaling pathway. Both proteins increase energy metabolism by controlling fatty acid oxidation, glucose intake, and lipolysis by activating the AMPK signal pathway \[[@B28-ijms-19-02556]\]. The resulting activation of these signaling mechanisms and the release of lipolysis-related hormones trigger a positive feedback pathway that enhances the activities of downstream genes regulating energy metabolism, further promotes catabolism and lipid mobilization, and accelerates the oxidation of fatty acids to supply energy and maintain the homeostasis of the energy metabolism in sheep under the persistent starvation state.

3.4. Inhibition of Lipid Droplet Fusion Ability in Combination with Enhanced Lipolysis {#sec3dot4-ijms-19-02556}
--------------------------------------------------------------------------------------

Both promotion of lipolysis and inhibition of fat deposition could lead to the reduction of rump fat accumulation in Altay sheep. The CIDEC protein is reported to promote fat accumulation and inhibit lipolysis, and knockout of the corresponding gene leads to a significant increase in the decomposition of TG in adipocytes and to accelerated energy metabolism \[[@B29-ijms-19-02556],[@B30-ijms-19-02556],[@B31-ijms-19-02556]\]. In our experiments, *CIDEC* mRNA and protein levels were significantly lower in the PS group, than in the FF group (*p* ≤ 0.01). These results support the theory that the downregulation of CIDEC inhibits lipid droplet fusion and delays the rate of fat deposition by blocking triglyceride aggregation, consistent with the sectioning and HE staining data obtained from Altay sheep rump adipocytes. Accordingly, we propose that persistent starvation in a harsh environment eventually leads to the withering of Altay sheep rump through combined inhibition of lipid synthesis and acceleration of fat decomposition.

3.5. Activation of Critical Genes for Maintaining Internal Homeostasis {#sec3dot5-ijms-19-02556}
----------------------------------------------------------------------

### 3.5.1. Insulin Resistance Promotes Lipolysis {#sec3dot5dot1-ijms-19-02556}

Insulin is reported to downregulate blood glucose to promote fat synthesis \[[@B32-ijms-19-02556]\]. RETN and HSP72 are adipocyte factors associated with insulin resistance. The expression of these factors at both the mRNA and protein levels was significantly higher in the PS than in the FF group (*p* ≤ 0.01). Our results indicate that under the persistent starvation state, the expression of these proteins is correlated to increased fat mobilization, promotion of energy release, and decomposition of rump fat in Altay sheep. On the other hand, these proteins could enhance insulin resistance, facilitating the maintenance of a constant blood glucose level, and provide protection for complex cell types and organ systems, such as the nervous system, blood cells, and the immune system, thus preventing the disruption of their physiological functions. These findings further support the association of the *RETN* and *HSP72* genes with insulin resistance \[[@B33-ijms-19-02556],[@B34-ijms-19-02556],[@B35-ijms-19-02556]\]. In addition, *CFD* expression in the PS group was significantly higher than in the FF group (*p* ≤ 0.01), in keeping with a previous report by Fan et al. \[[@B36-ijms-19-02556]\] that *CFD* mRNA is augmented in the catabolic state. On the basis of the collective data, we speculate that upregulation of CFD promotes lipolysis via insulin resistance. However, further studies are required to elucidate the precise mechanisms.

### 3.5.2. Initiation of Body Stress Mechanisms {#sec3dot5dot2-ijms-19-02556}

Persistent starvation usually triggers a series of abnormal reactions in the animal body, such as decreased heat production, hypothermia, decreased immunity, neuroendocrine dysfunction, and body fat consumption \[[@B37-ijms-19-02556]\]. Altay sheep subjected to persistent starvation showed consumption of body fat but no obvious immune disorders or neurological abnormalities, which may be attributable to the activation of specific genes involved in body self-protection and repair \[[@B38-ijms-19-02556],[@B39-ijms-19-02556]\]. Our iTRAQ results revealed significantly higher expression of HSP72 and Apo-AI in the PS group, compared to the FF group (*p* ≤ 0.01). The related genes are reported to exert anti-inflammatory and antioxidant effects \[[@B40-ijms-19-02556],[@B41-ijms-19-02556]\]. We hypothesize that, as a result of persistent starvation, HSP72 and Apo-AI are upregulated, activating the body stress mechanisms, and act to effectively reduce oxidative stress. These proteins contribute to cell protection and reduce inflammation, enhance body resistance, and reduce the likelihood of disease caused by malnutrition. Consequently, Altay sheep adapt to a series of adverse reactions caused by persistent starvation and are able to maintain internal homeostasis under harsh environmental conditions.

In summary, the extreme environment characterized by persistent cold and starvation stimulates the central nervous system in Altay sheep, leading to increased secretion of serum LEP and ADIPOQ. These hormones act on adipocytes through the AMPK signaling pathway and sympathetic adrenal axis to promote tail fat decomposition. Simultaneously, the expression levels of specific genes related to lipid metabolism are upregulated, such as *Apo-AI*, *LPL*, *LEP*, and *ADIPOQ*. These genes activate the AMPK and PPAR signaling pathways and form a positive loop to accelerate adipocyte decomposition. In addition, the *CIDEC* gene is downregulated, resulting in the inhibition of lipid droplet fusion and reduced accumulation of tail fat. We simultaneously identified a number of genes that play important roles in fat mobilization and internal homeostasis. (a) *RETN*, *HSP72*, and *CFD* were upregulated, which could enhance insulin resistance, accelerate tail fat decomposition and fatty acid oxidation, as well as effectively maintain a normal blood glucose level to provide protection to complex cell types and organ systems, such as the nervous system, blood cells, and the immune system, and enable their normal physiological functions under stress conditions. (b) *HSP72* and *Apo-AI* were upregulated, leading to the activation of stress mechanisms, the promotion of cell protection, and the reduction of inflammation, and consequently improving the adaptability of Altay sheep to persistent starvation. Thus, under environmental stress conditions, such as cold and starvation, the secretion of lipid metabolism-related hormones is increased, the key signaling pathways of fat mobilization and fatty acid oxidation are activated, and the effects of insulin resistance are enhanced, along with the simultaneous inhibition of fat synthesis, to ultimately accelerate Altay sheep tail fat decomposition and supply energy. During this process, a constant blood glucose level and stress state in the cells is maintained, and antioxidant and anti-inflammatory activities are enhanced ([Figure 5](#ijms-19-02556-f005){ref-type="fig"}). These regulatory processes collectively provide a molecular basis and material guarantee for improving the adaptability of Altay sheep to extreme environments. Our experiments additionally revealed significant changes in the expression of non-lipid metabolism-related genes, such as *p120GAP*, *PP2A*, *FLNA*, and *ITGA6*. The mRNA levels of each gene were consistent with the protein expression patterns. However, further research is warranted to ascertain whether these genes are involved in maintaining internal homeostasis in extreme states in Altay sheep as well as to understand their functions and molecular signaling.

4. Materials and Methods {#sec4-ijms-19-02556}
========================

4.1. Ethics Statement {#sec4dot1-ijms-19-02556}
---------------------

Procedures were performed according to the Guide for the Care and Use of Laboratory Animals and approved by the Experimental Animal Care and Use Committee of Xinjiang Academy of Agricultural and Reclamation Sciences (Shihezi, China, ethic committee approval number: XJNKKXY-AEP-039, 22 January 2012).

4.2. Experimental Design {#sec4dot2-ijms-19-02556}
------------------------

Three adult female Altay sheep in good physical condition with similar ages, body weights, and hip types were used. All animals were provided by the farm of Xinjiang Academy of Agricultural and Reclamation Sciences. All three sheep were given ample forage (500 g alfalfa and 200 g cottonseed hull) three times a day, with corn (200 g) as complementary feed at night, and water was provided ad libitum. After continuous feeding for four weeks, three adipose tissue samples from the left hip of each sheep were collected and represented the control group, designated FF. The wounds were sutured after sample collection, and the sheep were treated with antibiotics and provided food and drinking water ad libitum for a further four weeks. After their physiological conditions returned to the normal state, unit feed restriction was initiated (weekly feeding volume reduced by half along with ad libitum drinking water) for two weeks, followed by four weeks of complete fasting with unlimited drinking water. At the end of the starvation period, adipose tissue samples from the right hip were collected, representing the test group, designated PS.

The rump adipose tissue samples from each subgroup (FF and PS) were snap-frozen in liquid nitrogen and stored at −80 °C until use in iTRAQ proteomic and qPCR analyses for the identification and validation of protein factors and candidate genes.

4.3. Altay Sheep Rump Width Distribution {#sec4dot3-ijms-19-02556}
----------------------------------------

Rump widths of nine Altay sheep from three age groups (three months old, yearling, adult) were recorded monthly from May 2012 to May 2013.

4.4. Determination of the Serum Lipid Markers in Altay Sheep {#sec4dot4-ijms-19-02556}
------------------------------------------------------------

The sera of nine Altay sheep from the three age groups (three months old, yearling, adult) were collected at 10 am on day 9 of every month (between August 2012 and July 2013) and stored at −20 °C for the evaluation of serum lipid markers (APN, LEP, TG, TCH, and FFA) using enzyme-linked immunosorbent assay (ELISA, Blue Gene, Shanghai, China). The absorption values at 450 nm were assessed using an Enzyme Mark Instrument (Thermo Scientific, Waltham, MA, USA).

4.5. Frozen Sections and Hematoxylin-Eosin Staining {#sec4dot5-ijms-19-02556}
---------------------------------------------------

Tail fat tissue samples of nine Altay sheep from three age groups (young lamb, six months old, adult), three Wool sheep (adult), and six Altay sheep from the FF and PS groups were used to generate frozen sections 6 µm thick. One ethanol-fixed tail fat tissue sample from each subgroup was randomly selected for HE staining, sealed with neutral balata, and observed under a microscope.

4.6. iTRAQ Sample Preparation {#sec4dot6-ijms-19-02556}
-----------------------------

Six frozen tail fat tissue samples from the two subgroups (FF and PS) were transferred into SDT buffer (4% sodium dodecyl sulfate (SDS), 1 mM dithiothreitol (DTT), 150 mM Tris HCl, pH 8.0) and sonicated (80 W, ultrasonic 10 s, intermittent 15 s, a total of 10 times) on ice. After centrifugation at 14,000× *g* for 10 min, protein concentration was determined from an aliquot of supernatant with the Bicinchoninic acid assay. Each protein sample (60 μg) was digested with a trypsin solution (50 μg/mL) at 37 °C for 16 h. Following trypsin digestion, the peptides were dried via vacuum centrifugation and processed with the 8-plex iTRAQ reagent (Applied Biosystems, Foster City, CA, USA) as follows: FF 1 (113 tag), FF 2 (114 tag), FF 3 (114 tag), PS 1 (115 tag), PS 2 (116 tag), PS 3 (118 tag), and sample mix (119 tag), according to the manufacturer's instructions. After tagging, all samples were pooled, purified using Waters SepPak tC18 cartridges (Waters, Milford, MA, USA), and subjected to SCX fractionation with buffer A (10 mM KH2PO4, pH 3.0, 25% ACN) and buffer B (10 mM KH2PO4, pH 3.0, 500 mM KCl, 25% ACN). Tagging efficiency of \>99% was confirmed via mass spectrometry.

4.7. LC and MS/MS Analyses {#sec4dot7-ijms-19-02556}
--------------------------

The iTRAQ-labeled peptide mixtures were separated using an Easy LC nano-HPLC liquid-phase system with tray cooling comprising Buffer A (0.1% formic acid (FA)) and Buffer B (84% acetonitrile (ACN) and 0.1% FA). The peptides were loaded on a 2 cm × 100 μM and 75 μM × 100 mm EASY column (Thermo Scientific, Waltham, MA, USA), both filled with a 3 μM C18 trap column. The peptides were eluted in a linear gradient with buffer B from 0% to 35% over 100 min at a flow rate of 250 nL/min. MS analysis was performed on the liquid chromatographic eluent at a mass spectral range of 300--1800 m/*z* and accumulation time of 60 ms per spectrum.

4.8. Database Searches and Analysis of the Identified Proteins {#sec4dot8-ijms-19-02556}
--------------------------------------------------------------

Analyst Mascot 2.2 and Proteome Discoverer 1.4 (Thermo Scientific, Waltham, MA, USA) software were used to acquire the iTRAQ-based proteomic data. Paragon database search algorithm and integrated false discovery rate (FDR) analysis were implemented in ProteinPilot software (Applied Biosystems, Foster City, CA, USA) for peptide identification. A 99% confidence interval (CI) was set as the significance threshold for protein identification. The confidence level of each differentially expressed protein was calculated as a p-value using ProteinPilot, allowing the results to be evaluated on the basis not only of the magnitude but also of the confidence level of the change. Gene ontology (GO) was performed using the bioinformatics analysis tool DAVID (<http://david.abcc.ncifcrf.gov>) for the functional classification of the iTRAQ-identified proteins.

4.9. qPCR Analysis {#sec4dot9-ijms-19-02556}
------------------

qPCR was performed to validate the iTRAQ-based results. The expression levels of candidate genes in the FF and PS groups of Altay sheep were confirmed using the qPCR assay based on SYBR Green fluorescence (primer sequences are presented in [Table 4](#ijms-19-02556-t004){ref-type="table"}). The experiments were repeated three times with double-distilled water set as the negative control.

4.10. Data Analysis {#sec4dot10-ijms-19-02556}
-------------------

One-way ANOVA was conducted to evaluate changes between the FF and PS groups. Dependent variables were examined in terms of normality of variance. The effects of single treatments were analyzed with post-hoc tests at the same probability level after ANOVA was performed. For qPCR data analysis, the 2^−ΔΔ*C*t^ method was used to calculate the relative expression of candidate genes.
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Supplementary materials are available online at <http://www.mdpi.com/1422-0067/19/9/2556/s1>.
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![Changes in rump width and lipid marker levels in Altay sheep. (**A**) Rump widths of Altay sheep at three distinct stages of the life cycle recorded monthly from May 2012 to May 2013. (**B**) Serum adiponectin (APN) levels in Altay sheep from the three groups determined from August 2012 to July 2013. (**C**) Serum leptin (LEP) levels in Altay sheep from the three groups determined from August 2012 to July 2013. (**D**) Serum triglycerides (TG) levels in Altay sheep from the three groups determined from August 2012 to July 2013. (**E**) Serum total cholesterol (TCH) levels in Altay sheep from the three groups determined from August 2012 to July 2013. (**F**) Serum free fatty acid (FFA) levels in Altay sheep from the three groups determined from August 2012 to July 2013. The red, blue, and black lines represent the changes in adult, yearling, and three-month-old groups of sheep, respectively. In [Figure 1](#ijms-19-02556-f001){ref-type="fig"}A, the abscissa axis from 1 to 13 represents the months from May 2012 to May 2013. In [Figure 1](#ijms-19-02556-f001){ref-type="fig"}B--F, the abscissa axis from 1 to 12 represents the months from August 2012 to July 2013.](ijms-19-02556-g001){#ijms-19-02556-f001}

![Frozen sections of sheep adipose tissue and fat removal procedure. (**A**) Frozen sections of Altay sheep adipocytes at distinct stages of the life cycle. (**A1**) Young Altay sheep, (**A2**) Six-month-old Altay sheep, (**A3**) Adult Altay sheep. (**B**) Frozen sections of adult Altay and Wool sheep. (**B1**) Adult Altay sheep, (**B2**) Adult Wool sheep. (**C**) Frozen sections of tail adipose tissue from free-feeding and starvation-subjected Altay sheep. (**C1**) Free-feeding group, (**C2**) Persistent starvation group. Sections were observed under a microscope with a 40× objective. (**D**) Equivalent adipose tissue amounts from Altay and Wool sheep for extraction of RNA. Equivalent masses of adipose tissue from Altay sheep (28S and 18S RNA) were darker than those of Wool sheep, suggesting that the adipocytes of Altay sheep contain larger amounts of lipid droplets and less cytoplasm. (**E**) Fat removal surgery in Altay sheep. After barbering the wool, the rump fat was removed, and the skin sutured. After several months, the rump was restored, suggesting that fat deposition is also dependent on the adipocyte number.](ijms-19-02556-g002){#ijms-19-02556-f002}

![Protein classification according to molecular function. (**A**) In total, 7401 unique peptides, about 1610 protein, and 112 differentially expressed proteins were identified in the tail adipose tissue of Altay sheep from the FF and PS groups using iTRAQ combined with LC--MS/MS technology. (**B**) Total ion flow map of mass spectrometry. (**C**) Biological process-based classification of the about 1610 proteins. (**D**) Cellular component-based classification of the about 1610 proteins. (**E**) Molecular function-based classification of the about 1610 proteins.](ijms-19-02556-g003){#ijms-19-02556-f003}

![Expression and analysis of candidate genes related to fat development. (**A**--**L**) qPCR analysis of the expression patterns of lipid metabolism-related candidate genes adiponectin (*ADIPOQ*), resistin (*RETN*), lipoprotein lipase (*LPL*), apolipoprotein AI (*Apo-AI*), heat-shock protein 72 (*HSP72*), leptin (*LEP*), complement factor D (*CFD*), and cell death-inducing DFFA-like effector C (*CIDEC*)) and non-lipid metabolism-related candidate genes p120 GTPase activating protein (*p120GAP*), filamin A (*FLNA*), integrin alpha 6 (*ITGA6*), and protein phosphatase 2A (*PP2A*)) in the free-feeding (FF) and persistent starvation (PS) groups (\* *p* \< 0.05, \*\* *p* \< 0.01).](ijms-19-02556-g004){#ijms-19-02556-f004}

![Genes and signaling pathways involved in rump fat mobilization in response to continuous starvation. Under persistent starvation conditions, the synergistic actions of lipid metabolism-related hormones (LEP and ADIPOQ), key signaling pathways of fat mobilization and fatty acid oxidation (AMPK and PPAR), the fat synthesis-related gene *CIDEC*, insulin resistance-related genes (*HSP72*, *RETN*, and *CFD*), and antioxidant and anti-inflammatory genes (*HSP72* and *Apo-AI*) provide a molecular basis and material guarantee for improving the adaptability of Altay sheep to extreme environments. Red represents upregulated genes and blue represents downregulated genes; "+" promotion.](ijms-19-02556-g005){#ijms-19-02556-f005}
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###### 

Identification data related to the 112 proteins differentially expressed in the normally fed and starved groups.

  Accession No.   Gene                Protein Description                                       Coverage   Peptides   Theoretial MW/pI   FF/PS      *p*-Value
  --------------- ------------------- --------------------------------------------------------- ---------- ---------- ------------------ ---------- -----------
  Q5E9M1          *ARL6IP5*           PRA1 family protein 3                                     18.09      3          21.6/9.49          1.280389   0.001434
  F1MMU4          *H1FX*              H1 Histone Family, Member X                               7.01       1          22.3/10.71         2.019082   0.003628
  G1DFT2          *RPS4X*             Ribosomal Protein S4, X-Linked                            9.89       3          29.6/10.25         1.279684   0.0069
  Q3T0S6          *RPL8*              60S ribosomal protein L8                                  16.34      4          28.0/11.03         1.292493   0.007701
  D7R7V6          *GAPDH*             Glyceraldehyde-3-phosphate dehydrogenase                  42.94      14         35.8/8.35          1.174065   0.007889
  W5PGZ8          *APOF*              Apolipoprotein F                                          4.32       1          35.4/8.06          1.546838   0.00792
  W5PHJ8          *RP*                40S ribosomal protein                                     13.42      3          26.0/9/96          1.149951   0.008232
  A5D9B4          *HNRPH2*            Heterogeneous nuclear ribonucleoprotein H2                7.57       3          49.2/6.30          1.158449   0.008327
  F1MN90          *CIDEC*             Cell death-inducing DFFA like effector c                  6.84       1          27.3/7.97          1.224292   0.008439
  L8IUX9          *M91_16660*         Cytochrome b-c1 complex subunit 8                         8.54       1          9.6/10.33          1.228296   0.009478
  F1MXT1          *HACD2*             Very-long-chain (3*R*)-3-hydroxyacyl-CoA dehydratase      8.27       2          28.4/9.56          1.331041   0.010441
  W5QBL2          *CUL1*              Cullin 1                                                  1.05       1          87.4/8.22          1.225131   0.012333
  P20072          *ANXA7*             Annexin A7                                                6.7        3          49.9/6.80          1.252655   0.0138
  Q9XSK2          *CD63*              CD63 Molecule                                             4.2        1          25.7/7.64          1.750327   0.01455
  W5PED5          *CYP4V2*            CytochromeP450                                            7.78       3          61.0/7.15          1.417145   0.016098
  A4ZYA6          *VIM*               Vimentin                                                  72.75      37         53.6/5.09          1.370539   0.017049
  W5NY07          *ATL3*              Atlastin GTPase 3                                         11.5       6          60.0/5.71          1.437302   0.018839
  Q8WN55          *PTBP1*             Polypyrimidine tract-binding protein 1                    8.85       4          57.0/9.17          1.142094   0.021158
  L8I566          *M91_19776*         Coatomer subunit alpha                                    1.07       1          137.7/7.29         1.330717   0.021314
  F4YD28          *RPS24*             40S ribosomal protein S24                                 7..23      1          9.5/10.69          1.159825   0.022228
  W5P7F8          *TSPAN*             Tetraspanin                                               4.24       1          25.8/8.10          1.713756   0.022317
  W5PK26          *LASP1*             LIM and SH3 Protein 1                                     10         2          29.6/7.04          1.619281   0.02251
  A8D8X1          *RPL10*             Ribosomal Protein L10                                     18.69      5          24.5/10.14         1.363970   0.0233
  D3YC70          *HB*                Heparin-binding protein                                   25         1          5.6/8.61           1.230956   0.024758
  C3V9V7          *RNP24*             Ribonuclear protein 24                                    7.46       2          22.7/5.17          1.427028   0.024858
  W5PSJ3          *DCTN1*             Dynactin 1                                                2.62       3          143.0/5.85         1.184554   0.025664
  F1MBS3          *TGFBI*             Transforming growth factor-beta- induced protein ig-h3    13.16      7          72.2/7.12          1.500014   0.026213
  W5NSV5          *ITGA6*             Integrin Alpha 6                                          4.28       4          106.5/7.43         1.246541   0.026711
  E3SAZ8          *NPM1*              Nucleophosmin                                             12.07      4          32.1/4.85          1.283429   0.02941
  Q307E6          *COL1A1*            Collagen, Type 1, Alpha 1                                 8          1          15.5/9.12          3.591183   0.0297
  L8IR22          *M91_01904*         Basigin                                                   16.61      4          29.7/5.93          1.164516   0.0299
  Q5E971          *TMED10*            Transmembrane emp24 domain- containing protein 10         4.11       1          24.8/6.68          1.485596   0.03096
  W5PIP4          *AZU1*              Azurocidin 1                                              4.45       1          26.6/11.13         1.673528   0.031409
  Q30B83          *RPL35a*            Ribosomal protein L35a                                    14         1          5.8/9.78           1.211594   0.031542
  L8IPP0          *M91_20624*         78 kDa glucose-regulated protein                          36.03      19         72.3/5.16          1.105556   0.031702
  W5NSY8          *SH3BGRL*           SH3 domain-binding glutamic acid-rich- like protein       64.65      4          11.2/5.04          1.147976   0.031807
  C5IJ89          *RHEB*              Ras Homolog Enriched In Brain                             7.61       2          20.4/5.92          1.151032   0.0318
  W5QF34          *LMF2*              Lipase maturation factor                                  2.15       1          72.8/9.96          1.289405   0.034567
  D6BRG0          *ITGB*              Integrin, Beta                                            2.76       2          84.3/5.24          1.703519   0.0359
  L8HQV0          *M91_13225*         Dehydrogenase/reductase SDR family member 1               8.01       2          34/8.36            1.316582   0.03605
  A1L555          *PSAP*              Prosaposin                                                1.9        1          58.1/5.24          1.542171   0.03648
  W5P5A0          *FLNA*              Filamin A, Alpha                                          10.82      23         279.6/6.27         1.077701   0.0336
  L8IBL4          *M91_10571*         Lipoma-preferred partner                                  1.91       1          49.9/7.78          1.143675   0.037407
  K0IVJ6          *metallothionein*   Metallothionein                                           26.09      1          4.3/8.23           1.870961   0.038453
  W5PJD0          *PGM2*              Phosphoglucomutase 2                                      1.2        1          64.9/6.44          1.18212    0.039518
  W5P263          *ABHD5*             alpha/beta hydrolase domain-containing protein 5          2.4                   37.2/8.10          1.399659   0.040579
  L8HSP5          *M91_02935*         Basic leucine zipper and W2 domain-containing protein 1   6.86       3          48.4/5.77          1.529994   0.042248
  P07514          *CYB5R3*            NADH-cytochrome b5 reductase 3                            44.19      11         34.0/7.28          1.304232   0.042261
  W5NVF1          *CYBRD1*            Cytochrome B Reductase 1                                  5.88       1          22.3/9.27          2.219898   0.042413
  A6QQR5          *TMEM43*            Transmembrane Protein 43                                  9          3          44.7/8.70          1.578646   0.044298
  W5QHC9          *EPB42*             Erythrocytemembrane protein band 42                       11.87      8          77.2/6.85          1.263628   0.04501
  Q3SZF2          *ARF4*              ADP-Ribosylation Factor 4                                 35         2          20.5/6.18          1.683021   0.0453
  L8IHC9          *M91_15717*         Uncharacterized protein                                   11.11      1          6.2/9.48           1.095345   0.045529
  W5PN85          *ACAT1*             Acyl-coenzyme A:cholesterol acyltrans- ferase             24.36      9          45.4/8.55          1.382609   0.049793
  W5Q2N1          *p120GAP*           Ras GTPase-activating protein                             1.19       1          106.0/7.76         0.733429   0.00144
  A0FI82          *LPL*               Lipoprotein lipase                                        5.65       2          53.5/8.36          0.701299   0.004433
  W5QA54          *LOC101119629*      Uncharacterized protein                                   7.08       1          22.4/5.31          0.273731   0.005858
  P02510          *CRYAB*             Alpha-crystallin B chain                                  25.14      4          20.0/7.32          0.749447   0.006911
  B0BL70          *mbl*               Mannose-binding lectin                                    4.42       1          26.5/4.89          0.626459   0.008106
  Q1JPJ2          *XPNPEP1*           Xaa-Pro aminopeptidase 1                                  3.53       2          69.7/5.68          0.860442   0.008278
  Q2KIL3          *ALAD*              Delta-aminolevulinic acid dehydratase                     10.03      2          36.1/6.99          0.570859   0.008597
  F1N2I5          *CMBL*              Carboxymethylenebutenolidase                              8.16       2          27.9/7.07          0.675716   0.009004
  L8IMU6          *PP2A*              Protein Phosphatase 2 Alpha                               8.3        1          28.7/5.43          0.719336   0.009013
  L8IEF9          *M91_08893*         Vacuolar protein sorting-associated protein 28 homolog    5.94       1          22.7/8.42          0.656248   0.009294
  A7XV32          *HSP72*             Heat Shock Protein 72                                     28.24      18         70.3/5.65          0.806279   0.010322
  A0A0U1YZ59      *ADIPOQ*            Adiponectin                                               31.8       5          25.9/6.3           0.764493   0.0107
  H9A6H7          *MSTN*              Myostatin                                                 6.17       1          9.3/5.17           0.294348   0.0127
  W5PCD1          *LOC101110151*      Uncharacterized protein                                   19.15      3          15.3/5.19          0.771917   0.013342
  F1N5Q0          *ST*                Sulfotransferase                                          3.14       1          26.5/8.83          0.793002   0.013347
  W5QGT1          *CUL3*              Uncharacterized protein                                   2.68       2          86.4/7.98          0.79521    0.013851
  B6UV62          *SERPINF1*          SERPINF1                                                  18.03      7          45.9/7.95          0.624886   0.014795
  W5NX51          *APOA1*             Apolipoprotein A-I                                        65.64      22         29.5/6.20          0.489784   0.015501
  L8IVL6          *M91_02549*         Glutamate-cysteine ligase catalytic subunit               6.3        3          66.6/5.57          0.65182    0.015547
  L8IZ67          *M91_00380*         Glutaredoxin-3                                            4.19       1          35.0/6.18          0.715634   0.015974
  Q762I5          *RETN*              Resistin                                                  18.74      1          5.6/8.69           0.799622   0.0167
  W5QDD0          *LOC101108092*      Uncharacterized protein                                   59.83      15         26.7/7.00          0.737769   0.017758
  Q3T0A3          *CFD*               Complement factor D                                       67.85      2          61.1/7.53          0.698614   0.018044
  P29701          *AHSG*              Alpha-2-HS-glycoprotein                                   46.15      12         38.6/5.37          0.720115   0.01812
  W5P8E1          *DNPH1*             2′-deoxynucleoside 5′-phosphate *N*-hydrolase 1           5.75       1          18.7/5.40          0.833179   0.020246
  Q32LE5          *ASRGL1*            Isoaspartyl peptidase/[l]{.smallcaps}-asparaginase        6.82       2          32.0/7.40          0.730442   0.020663
  D6PZY4          *fH*                Factor H                                                  9.09       10         125.2/6.71         0.772665   0.020943
  W5PJ97          *APOA2*             Apolipoprotein A-II                                       25.49      2          11.2/8.10          0.456384   0.02237
  W5Q961          *LOC101107947*      Uncharacterized protein                                   7.48       2          28.3/5.79          0.67714    0.022512
  L8IFD5          *M91_10356*         Guanine nucleotide-binding protein subunit alpha-13       5          2          44.3/7.22          0.837336   0.024252
  W5Q0Y4          *FAH*               Fumarylacetoacetase                                       12.25      5          43.9/7.40          0.937515   0.024511
  W5P214          *TAGLN*             Transgelin                                                40.89      8          25.0/8.95          0.701171   0.02459
  I1U3B9          *ALDH1L1*           Aldehyde Dehydrogenase 1 Family, Member L1                4.08       1          56.1/7.63          0.670099   0.0248
  Q3SZA0          *COPS4*             COP9 signalosome complex subunit 4                        11.58      4          46.2/5.83          0.838176   0.024938
  L8I8L3          *M91_03748*         Vesicle-associated membrane protein 4                     5.04       1          16.1/6.04          0.475656   0.026818
  A1L5B0          *MYL9*              Myosin regulatory light polypeptide 9                     39.88      5          19.3/4.85          0.825417   0.028267
  W5Q7J0          *APOB*              Apolipoprotein B                                          7.65       30         513.8/7.12         0.779207   0.02886
  L8I9W2          *M91_02159*         Tyrosine-protein phosphatase non- receptor type 11        3.54       2          67.8/7.16          0.931432   0.032163
  I1W1N3          *RAB18*             Member RAS Oncogene Family                                5.34       1          22.9/5.23          0.815468   0.0336
  W5PE22          *GDI2*              Rab GDP dissociation inhibitor                            35.58      13         48.8/6.97          0.841934   0.034471
  Q28603          *LEP*               Leptin                                                    3.79       4          16.1/5.71          0.792210   0.0352
  W5Q8X9          *PGP*               P-glycoprotein                                            5.91       1          25.1/5.28          0.776609   0.035498
  W5NTW3          *ITIH1*             Inter-alpha-trypsin inhibitor heavy chain H1              12.06      9          101.5/7.26         0.530584   0.037196
  C6ZP47          *HBA1*              I alpha globin                                            95.77      1          15.1/8.67          0.508000   0.0377
  W5PFC9          *LOC101117129*      Uncharacterized protein                                   28.09      15         77.8/6.60          0.670015   0.039088
  W5NZJ1          *LOC101114075*      Sulfotransferase                                          12.54      4          34.3/6.94          0.69946    0.039392
  W5PR48          *HPRT1*             Hypoxanthine-guanine phosphoribosyltransferase 1          13.76      3          24.6/7.09          0.708477   0.039453
  A6H7G2          *DBNL*              Drebrin-like protein                                      4.73       1          47.69/4.98         0.635779   0.041767
  L8I9D6          *M91_05702*         B-cell lymphoma 3 protein                                 3.66       1          40.1/7.18          0.428236   0.041814
  W5NR71          *DIAPH1*            Diaphanous 1                                              1.36       1          138.4/5.51         0.764331   0.042049
  B9VH04          *UQCRH*             Cytochrome b-c1 complex subunit 6                         28.57      2          10.6/4.50          0.811089   0.042158
  P15497          *APOA1*             Apolipoprotein A-I                                        59.25      21         30.2/5.97          0.385227   0.04279
  Q5E9A6          *VPS25*             Vacuolar protein-sorting-associated protein 25            8.52       1          20.7/6.34          0.794093   0.044223
  W5PU66          *IQGAP1*            IQ motif containing GTP ase activating protein 1          8.87       12         192.8/6.37         0.908765   0.044485
  L8IBI3          *M91_18442*         Terminal uridylyltransferase 7                            1.08       1          168.8/7.06         0.390906   0.044636
  W5P6Y6          *AK8*               Adenylatekinase 8                                         5.85       1          54.7/6.72          0.755031   0.046026
  L8I977          *M91_12085*         Actin-related protein 10                                  3.48       1          44.7/7.62          0.791158   0.048268
  W5QIC3          *PRUNE*             Uncharacterized protein                                   4.74       1          48.8/5.28          0.512771   0.048663
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###### 

Genes related to lipid metabolism.

  Gene Name   Gene Ontology, Molecular Function
  ----------- -------------------------------------------------------------------------------------
  *GPIHBP1*   Lipase binding; Lipid binding; Lipoprotein particle binding;
  *AHSG*      Glucose, Energy Metabolism; Lipid binding
  *CYP450*    Cholesterol, steroids and other lipids synthesis
  *CYB5R3*    Cholesterol biosynthetic
  *HACD2*     Fatty Acyl-CoA Biosynthesis
  *LPL*       Lipoprotein lipase activity; Triglyceride lipase activity; Phospholipase activity
  *Apo-AI*    Lipid transporter activity; Phospholipid binding; Phospholipid transporter activity
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###### 

Proteins involved in the representative KEGG pathways.

  Pathways                      Proteins
  ----------------------------- -------------------------
  PPAR signaling pathway        Apo-AI, LPL
  AMPK signaling pathway        PP2A
  PI3K--Akt signaling pathway   Cdc37, PP2A, ITGB, ITGA
  Oxidative phosphorylation     UQCRH
  MAPK signaling pathway        FLNA, HSP72, p120GAP
  Glycerolipid metabolism       3.1.1.34
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###### 

Primer sequences and PCR product sizes.

  ----------------------------------------------------------------------------
  Gene        Accession No.   Primer Sequence (5′→3′)      Product Size (bp)
  ----------- --------------- ---------------------------- -------------------
  *GAPDH*     NM_001190390    F: CTGACCTGCCGCCTGGAGAAA\    149
                              R: GTAGAAGAGTGAGTGTCGCTGTT   

  *ADIPOQ*    KM216385.1      F: AGTGGTGCCGTCATAGTGG\      138
                              R: CAGTGTAAATGGGGATGTGG      

  *RETN*      KJ704841.1      F: GCAGCACCTGCAGGATGAAG\     263
                              R: GTGGTCTCAGCACGCACGTC      

  *CFD*       XM015093908.1   F: TATCACGACGGCACCATCAC\     160
                              R: TACCGGGCTTCTTGCGGTTG      

  *FLNA*      FJ458435.1      F: CCATCGACGGGCCTTCCAAG\     234
                              R: TGGCAGTCTTGGTCAGGGAG      

  *p120GAP*   XM015096185.1   F: CATCCTGAGTCCACGGATGT\     219
                              R: GGAAGTTCAGGTACATTCCC      

  *PP2A*      XM012116023.2   F: GAGGGAATCATGAAAGCCGT\     261
                              R: CAGACCATAAGAGATCACAC      

  *LEP*       XM012177090.2   F: CCTATCTCTCCTACGTGGAGG\    213
                              R: GGATCTGTTGGTAGATTGCCA     

  *ITGA6*     XM012120035.2   F: GTGGCCATTCTTGCTGGGAT\     222
                              R: CTATCATCGTACCTAGAGCG      

  *LPL*       NM001009394.1   F: GCTGCTGGTATTGCAGGAAG\     308
                              R: CACTTCACTAGCTGGTCCAC      

  *HSP72*     NM001267874.1   F: ACCATCCCCACGAAGCAGAC\     337
                              R: CCTCGTCCTCTGCCTTGTAC      

  *Apo-AI*    XM012095497.1   F: GCCCAATTTGAAGCCTCCGC\     246
                              R: TCTGGCGGTAGATCTCCACC      

  *CIDEC*     KM199684        F: ATGGAATACGCCAAGAAGTC\     300
                              R: GGATTGGAAATACCCTTCTG      
  ----------------------------------------------------------------------------

[^1]: These authors contributed equally to this work.
